CYP2C8
HGNC:2622 · SaudiVarKB evidence summary derived from retained literature mentions.
6Gene mentions
6Publications
4Linked variants
2Associated phenotypes
Associated phenotypes
Co-mentioned in CYP2C8 publications| Phenotype | Identifier | Articles | Mentions |
|---|---|---|---|
| diabetes mellitus | — | 1 | 1 |
| rheumatoid arthritis | — | 1 | 1 |
Linked variants
Variants normalized to CYP2C8Population context
Reported in the same publications| Country / region | Group | Cohort | Articles |
|---|---|---|---|
| Saudi Arabia | — | — | 1 |
| Saudi Arabia | — | 140 | 1 |
| Saudi Arabia | — | 786 | 1 |
| Not specified | — | 218 | 1 |
Supporting publications
6 records- 2026USFDA-Approved Small Molecules in the Year 2025: Medicinal Chemistry Strategies and Trends.Archiv der PharmaziePubMed ↗
- 2024Pediatric pharmacogenetics: profiling CYP2C8 polymorphisms at King Abdulaziz University Dental Clinic.Drug metabolism and personalized therapyPubMed ↗
- 2023Targeted next-generation sequencing of genes involved in Warfarin Pharmacodynamics and pharmacokinetics pathways using the Saudi Warfarin Pharmacogenetic study (SWAP).The pharmacogenomics journalPubMed ↗
- 2023Association of CYP2C9∗3 and CYP2C8∗3 Non-Functional Alleles with Ibuprofen-Induced Upper Gastrointestinal Toxicity in a Saudi Patient.Case reports in medicinePubMed ↗
- 2021Utilizing Large Electronic Medical Record Data Sets to Identify Novel Drug-Gene Interactions for Commonly Used Drugs.Clinical pharmacology and therapeuticsPubMed ↗
- 2017Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.Clinical and experimental pharmacology & physiologyPubMed ↗